Pre-operative Focused Transthoracic Echocardiography for Prediction of Post-operative Cardiac Complications

Diastolic Dysfunction Clinical Trial

Official title:

Pre-operative Focused Transthoracic Echocardiography for Prediction of Post-operative Cardiac Complications

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04114474
• Other study ID #: transthoracic echocardiograpy
• Status: Completed
• Start date: October 1, 2017
• Est. completion date: December 30, 2018

Study information

• Verified date: October 2019
• Source: South Egypt Cancer Institute
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The extent focused transthoracic echocardiography when done pre-operatively to patients admitted for elective surgery and suspected to be at risk of cardiac disease specially the geriatric population can affect perioperative anesthetic management of these patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: December 30, 2018
• Est. primary completion date: December 1, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 60 Years to 80 Years

Eligibility

Inclusion Criteria:

• Patients above 60 years of age ASAI and ASA II were included

Exclusion Criteria:

• history of cardiac disease, history of previous postoperative cardiac complications and symptoms or signs of cardiac diseases.

Related Conditions & MeSH terms

• Diastolic Dysfunction

Intervention

Diagnostic Test:
• TRANSTHORACIC ECHOCARDIOGRAPY
TTE (Vivid I echocardiography machine General Electric Healthcare, Milwaukee, WI, USA) with a 3S-RS (1.5-3.6 MHz) transthoracic probe). was done by professional anesthesiologist following the :Hemodynamic Echocardiography Assessment in Real Time ( HEART) protocol. According to the clinical findings of TTE patients may be either free or have one or more of the following haemodynamic states normal, empty, vasodilated ,left ventricular systolic or diastolic failure, left ventricular systolic and diastolic failure, and right ventricular failure, valve stenosis or regurgitation of at least moderate severity

Locations

Country	Name	City	State
Egypt	South Egypt Cancer Institute, Assiut University, Arab Republic of Egypt	Assiut

Sponsors (1)

Lead Sponsor	Collaborator
South Egypt Cancer Institute

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Lt. Ventricular EDV	Transthoracic echocardiography (TEE) LVEDV	Change from Baseline pre operative LVEDV to first day postoperative